TY  - RPRT
TI  - Therapeutically advantageous secondary targets of abemaciclib identified by multi-omics profiling of CDK4/6 inhibitors
AU  - Hafner, M.
AU  - Mills, C. E.
AU  - Subramanian, K.
AU  - Chen, C.
AU  - Chung, M.
AU  - Boswell, S. A.
AU  - Everley, R. A.
AU  - Walmsley, C. S.
AU  - Juric, D.
AU  - Sorger, P.
PY  - 2017
DO  - 10.1101/211680
UR  - https://www.biorxiv.org/content/10.1101/211680v1
ID  - 10.1101/211680
ER  -